- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Role of novel type I interferon epsilon in mucosal immunity ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Creator
-
Xi, Y.
- Contributor
-
Day, SL
Jackson, RJ
Ranasinghe, C.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-P192
- URN
-
urn:nbn:de:1111-2016080728296
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Xi, Y.
- Day, SL
- Jackson, RJ
- Ranasinghe, C.
- SpringerLink (Online service)
Other Objects (12)
Interferon-lambda : a cytokine controlling innate and adaptive antiviral mucosal immunity
Functional differences in type I versus type III interferon mediated immunity
Functional differences in type I versus type III interferon mediated immunity
Type I interferon-mediated tumor immunity and its role in immunotherapy
Mucosal immunity : IgA and polymorphonuclear neutrophils
The P2X7 receptor in mucosal adaptive immunity
ADAM9 promotes type I interferon-mediated innate immunity during encephalomyocarditis virus infection
Mucosal prime with a replicating vaccinia-based vaccine promotes mucosal immunity against SIV
CCL5 regulation of mucosal chlamydial immunity and infection
Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis
Peli1 negatively regulates type I interferon induction and antiviral immunity in the CNS
Trained immunity of alveolar macrophages requires metabolic rewiring and type 1 interferon signaling
Interferon-lambda : a cytokine controlling innate and adaptive antiviral mucosal immunity
Functional differences in type I versus type III interferon mediated immunity
Functional differences in type I versus type III interferon mediated immunity
Type I interferon-mediated tumor immunity and its role in immunotherapy
Mucosal immunity : IgA and polymorphonuclear neutrophils
The P2X7 receptor in mucosal adaptive immunity
ADAM9 promotes type I interferon-mediated innate immunity during encephalomyocarditis virus infection
Mucosal prime with a replicating vaccinia-based vaccine promotes mucosal immunity against SIV
CCL5 regulation of mucosal chlamydial immunity and infection
Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis
Peli1 negatively regulates type I interferon induction and antiviral immunity in the CNS
Trained immunity of alveolar macrophages requires metabolic rewiring and type 1 interferon signaling
Interferon-lambda : a cytokine controlling innate and adaptive antiviral mucosal immunity
Functional differences in type I versus type III interferon mediated immunity
Functional differences in type I versus type III interferon mediated immunity
Type I interferon-mediated tumor immunity and its role in immunotherapy
Mucosal immunity : IgA and polymorphonuclear neutrophils
The P2X7 receptor in mucosal adaptive immunity
ADAM9 promotes type I interferon-mediated innate immunity during encephalomyocarditis virus infection
Mucosal prime with a replicating vaccinia-based vaccine promotes mucosal immunity against SIV
CCL5 regulation of mucosal chlamydial immunity and infection
Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis
Peli1 negatively regulates type I interferon induction and antiviral immunity in the CNS